Literature DB >> 10417196

Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide.

C Y Chiang1, G Kyritsis, D T Graves, S Amar.   

Abstract

The present study was undertaken to test the hypothesis that tumor necrosis factor (TNF) and/or interleukin-1 (IL-1) activity mediates lipopolysaccharide (LPS)-induced bone resorption in vivo. To test this hypothesis, Escherichia coli LPS or Porphyromonas gingivalis LPS was injected into the subcutaneous tissues overlying mouse calvariae. Histological sections, prepared from the center of the lesion, were stained for tartrate-resistant acid phosphatase, and histomorphometric analysis was performed to quantify the osteoclast number and the area of bone resorption. In time course experiments using normal mice, a peak of bone resorption occurred 5 days after endotoxin stimulation. In dose-response experiments, IL-1 receptor type 1 deletion (IL-1R(-/-)), TNF double-receptor p55/p75 deletion (TNF p55(-/-)/p75(-/-)), combined TNF p55 and IL-1 receptor type 1 deletion (TNF p55(-/-)/IL-1R(-/-)), and IL-1beta-converting enzyme-deficient (ICE(-/-)) mice and the respective wild-type mice were injected with 500, 100, or 20 micrograms of P. gingivalis LPS and sacrificed 5 days after LPS injection. At the highest dose (500 micrograms), significant decreases in osteoclast number occurred in mutant mice compared to wild-type mice: (i) a 64% reduction for the TNF p55(-/-)/IL-1R(-/-) mice, (ii) a 57% reduction for the IL-1R(-/-) mice, (iii) a 41% reduction for the TNF p55(-/-)/p75(-/-) mice, and (iv) a 38% reduction for the ICE(-/-) mice. At the two lower doses, bone resorption was apparent but no significant differences between mutant and wild-type animals were observed. The present data indicate that at higher doses, LPS-induced bone resorption is substantially mediated by IL-1 and TNF receptor signaling. Furthermore, IL-1 receptor signaling appears to be slightly more important than TNF receptor signaling. At lower LPS doses, other pathways leading to osteoclast activity that are independent of TNF and IL-1 are involved.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417196      PMCID: PMC96729     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Phenotypic and functional characterization of mice that lack the type I receptor for IL-1.

Authors:  M B Glaccum; K L Stocking; K Charrier; J L Smith; C R Willis; C Maliszewski; D J Livingston; J J Peschon; P J Morrissey
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

2.  Reactive change in proliferative activity of the junctional epithelium after topical application of lipopolysaccharide.

Authors:  T Takata; M Miyauchi; I Ogawa; H Ito; J Kobayashi; H Nikai
Journal:  J Periodontol       Date:  1997-06       Impact factor: 6.993

3.  TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.

Authors:  J J Peschon; D S Torrance; K L Stocking; M B Glaccum; C Otten; C R Willis; K Charrier; P J Morrissey; C B Ware; K M Mohler
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

4.  Constitutive shedding of both p55 and p75 murine TNF receptors in vivo.

Authors:  J K Pinckard; K C Sheehan; C D Arthur; R D Schreiber
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

5.  Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.

Authors:  Y Abu-Amer; F P Ross; J Edwards; S L Teitelbaum
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 6.  Advances in bone biology: the osteoclast.

Authors:  G D Roodman
Journal:  Endocr Rev       Date:  1996-08       Impact factor: 19.871

7.  Local bone injections of LPS and M-CSF increase bone resorption by different pathways in vivo in rats.

Authors:  P Orcel; M Feuga; J Bielakoff; M C De Vernejoul
Journal:  Am J Physiol       Date:  1993-03

8.  Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.

Authors:  R B Kimble; A B Matayoshi; J L Vannice; V T Kung; C Williams; R Pacifici
Journal:  Endocrinology       Date:  1995-07       Impact factor: 4.736

9.  Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors.

Authors:  J Ruby; H Bluethmann; J J Peschon
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more
  61 in total

Review 1.  Animal models to study host-bacteria interactions involved in periodontitis.

Authors:  Dana T Graves; Jun Kang; Oelisoa Andriankaja; Keisuke Wada; Carlos Rossa
Journal:  Front Oral Biol       Date:  2011-11-11

2.  Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss.

Authors:  X Yuan; J Cao; T Liu; Y-P Li; F Scannapieco; X He; M J Oursler; X Zhang; J Vacher; C Li; D Olson; S Yang
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

3.  Transplantation of SHED prevents bone loss in the early phase of ovariectomy-induced osteoporosis.

Authors:  Y Liu; L Wang; S Liu; D Liu; C Chen; X Xu; X Chen; S Shi
Journal:  J Dent Res       Date:  2014-09-24       Impact factor: 6.116

4.  Identification and Characterization of MicroRNA Differentially Expressed in Macrophages Exposed to Porphyromonas gingivalis Infection.

Authors:  Olivier Huck; Jacob Al-Hashemi; Laetitia Poidevin; Olivier Poch; Jean-Luc Davideau; Henri Tenenbaum; Salomon Amar
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

5.  Loss of interleukin-10 exacerbates early Type-1 diabetes-induced bone loss.

Authors:  Naiomy D Rios-Arce; Andrew Dagenais; Derrick Feenstra; Brandon Coughlin; Ho Jun Kang; Susanne Mohr; Laura R McCabe; Narayanan Parameswaran
Journal:  J Cell Physiol       Date:  2019-09-19       Impact factor: 6.384

6.  Xylitol inhibits inflammatory cytokine expression induced by lipopolysaccharide from Porphyromonas gingivalis.

Authors:  Su-Ji Han; So-Yeon Jeong; Yun-Ju Nam; Kyu-Ho Yang; Hoi-Soon Lim; Jin Chung
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

7.  Whole Body Vibration Reduces Inflammatory Bone Loss in a Lipopolysaccharide Murine Model.

Authors:  I S Kim; B Lee; S J Yoo; S J Hwang
Journal:  J Dent Res       Date:  2014-05-08       Impact factor: 6.116

8.  Anticytokine therapy for periodontal diseases: Where are we now?

Authors:  Yogesh Prakash Waykole; S S Doiphode; P S Rakhewar; Maya Mhaske
Journal:  J Indian Soc Periodontol       Date:  2009-05

Review 9.  Interaction of staphylococci with bone.

Authors:  John A Wright; Sean P Nair
Journal:  Int J Med Microbiol       Date:  2009-11-03       Impact factor: 3.473

10.  Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge.

Authors:  Salomon Amar; Qingde Zhou; Yazdani Shaik-Dasthagirisaheb; Susan Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.